Lilly Rakes in $790M From Amylin; FDA OKs Talon's Rare Leukemia Drug - Aug. 10, 2012

Having trouble viewing this email? View in Browser.

Friday, August 10, 2012  |   |   |   |  Pharm-Olam has offices among the most populated cities in Europe, Latin America, India, South Africa, and the USA to provide for oncology studies of all sizes. Pharm-Olam has helped bring 2 oncology compounds to NDA approval and have conducted oncology studies in over 30 countries. Our Executive VP of Clinical Development will speak at the 5th annual Oncology Clinical Trials in Emerging Regions conference in Morristown, NJ October 22 - 23. Sponsors can visit the Pharm-Olam website to obtain a 20% discount code. The incidence of oncology indications and standards of treatment can vary widely, so let Pharm-Olam conduct a complimentary feasibility study specific to your protocol and study budgets to use in your resource planning. Contact us at www.pharm-olam.com, info@pharm-olam.com, USA 1-713-559-7900, UK 44-0-1344-891121.   •  Eli Lilly and Company (LLY) Rakes in $790 Million From Amylin Pharmaceuticals, Inc. (AMLN) More... •  FDA OKs Talon Therapeutics, Inc. (TLON.OB)'s Rare Leukemia Drug More... •  Pfizer Inc. (PFE)'s Torisel Drug Fails in a Combination Study More... •  Roche (RHHBY) Says Avastin Slows Brain Cancer Tumor Growth More... •  Intercept Pharmaceuticals Closes $30 Million Series C Financing More... •  AmerisourceBergen Corporation (ABC) Subpoenaed in U.S. Drug Probe More... •  Ex-Pfizer Inc. (PFE) Chief, Joins VC Firm Lux Capital More... •  Icahn Accuses Forest Laboratories, Inc. (FRX) of Hiding Poison Pill Agreements More... More Top News Sign Up for a No-Obligation Free Trial to "The Gray Sheet" Your one month trial will include 30 days of online access, email updates delivered to your inbox, and topical RSS feeds. Most importantly, you will catch a glimpse of what your competitors are learning every day thanks to the insight and expertise that can only be offered by "The Gray Sheet". You can also download one popular article from a recent issue, "FDA's UDI Draft Rule Details Device Marking, Database Submission Mandates". Please Click Here for Free Trial. Please Click Here for Article Download. •  Grapes May Help Protect Men's Heart Health, University of Connecticut Study More... •  Smoking Found to Double Risk of Leukemia, Lymphoma in Women, Oxford University Study More... •  Bowel Cancer Caused by Faulty Genes and Iron Levels, University of Birmingham Study More... •  Effective Antibodies Against Flu Strains Identified, The Scripps Research Institute, Crucell Vaccine Institute Study More... •  Brain Stem Cells Possibly Responsible for Bigger Brains, The Scripps Research Institute Reveals More... •  Statins' Heart Benefits Outweigh Diabetes Risk, Brigham and Women's Hospital Study More... •  Student Scores Improve If Teachers Given Incentives Upfront, University of Chicago Study More... •  Why Living in the Moment is Impossible, University of Pittsburgh Study More...   More Featured News The 6th Annual Pain Therapeutics October 3 - 4, 2012 San Francisco, CA Event Website ARROWHEAD'S ANNUAL PAIN THERAPEUTICS SUMMIT is the US's premier conference covering the field of pain management and therapeutics. Leaders from the pharmaceutical, biotech, device and medical communities attend this conference to learn about the latest advances in the treatment of various types of pain and to network with colleagues from industry, the non-profit sector, academia, the medical community, government and investors. This conference will provide attendees with thoughtful insight from key industry leaders and academic researchers concerning cutting edge drug discovery science, preclinical development trends, analysis of key clinical-stage pain therapies and newly marketed products. We will highlight the most important developments in recent years in the field, including new research in CGRP antagonists, NGF antagonists, Nav 1.7 antagonists, new research in biologic therapies and the genetic component of pain, abuse-resistant opioids, analysis of FDA's REMS program and a plethora of other topics. Please click here for more information. • Biotech Bay (South San Francisco, California) Catalyst Biosciences, Inc. Scientist/Staff Scientist, Assay Development & Screening Responsible for the development and execution of assays to support Catalyst's Alterase platform for identifying therapeutic proteases. In addition to this primary responsibility, the successful candidate will also play an important role in other aspects of the lead discovery process, including target validation and prototyping of assays for transfer to the Screening group • Pharm Country (Summit, New Jersey) Hurley Consulting Associates Regulatory Affairs Submission Specialist Familiarity with FDA and ICH guidelines, including knowledge of regulatory requirements specific to electronic submissions, and differences and similarities across regions. Ability to format and compile documents according to requirements specified by regulatory agencies. Generate submission-ready documents. Compile compliant eCTD submissions on a XML backbone. • Genetown (Lexington, Massachusetts) Shire Senior LIMS Developer Will play a significant role in the ongoing development and maintenance of the LabWare LIMS system. Responsibilities may include Crystalreport creation, LIMS configuration, as well as new functionality development and implementation. • Biotech Beach (Santa Monica, California) Astellas Pharma US Manufacturing Associate I, Cell Culture Perform a variety of clinical manufacturing activities, including Cell Culture and filtration operation of bioprocess systems. Operations are predominately performed in a clean room and are conducted under GMP guidelines. • BioMidwest (Bedford, Ohio) Boehringer Ingelheim Pharmaceuticals, Inc. Specialist II Will be actively involved in improvement projects that are based upon functional and organizational priorities. Each project must be aligned with the BVL Site Strategy while supporting functional and corporate pharmaceutical production strategies. This person will employ Lean / Six Sigma / Business Process Excellence tools and approaches to bring about very focused process improvement at the tactical / functional levels within BVL. Get Noticed! Add your resume to the BioSpace Career Center! See more than 5,000 job postings in the BioSpace Career Center! 2012 Pharm Country Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the tri-state area. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • Pharm Country Career Fair, Bridgewater, NJ September 13, 2012 • Biotech Beach Career Fair, San Diego, CA September 20, 2012 • Biotech Bay Career Fair, Burlingame, CA October 3, 2012 • BioCapital Career Fair, Bethesda, MD October 9, 2012 • BioMidwest Career Fair, Lincolnshire, IL October 22, 2012 • Bio NC Career Fair, Durham, NC October 25, 2012 • Genetown Career Fair, Cambridge, MA November 5, 2012 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services The Stem Cell Market Outlook • Identify potential growth markets with sales forecasts by indication and expected timing of market entry. • Compare the different business models for stem cell therapies. • Evaluate which novel products offer the greatest potential clinical advances over the next several years and why. Click Here for More Information. Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set. Request Now! Alder Biopharmaceuticals Inc. Corporate Headquarters 11804 North Creek Parkway South Bothell, Washington 98011 U.S.A. Phone: 425-205-2900 Fax: 425-205-2901 Alder is revolutionizing the way antibody therapies are identified, selected, developed and produced. Our proprietary technologies make great strides possible in the field of antibody therapeutics, dramatically accelerating the way pharmaceutical and biotechnology companies bring new therapies to market. More Company Profiles FREE Subscription to Laboratory Equipment Laboratory Equipment magazine reaches lab managers, supervisors and research directors with buying responsibility in research, quality control and testing laboratories located in industry, government and universities, giving them the latest tools to conduct better, more cost-efficient and effective scientific research. Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship BioSpace Inc. 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 BioSpace Inc. 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the BioSpace News Beat Team. Editor & Publisher: Lana Ho Editorial & Production Staff: Maysa Darwish, Tammy Liu BioSpace.com - Life. Science. Community. • BioSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2012 BioSpace http://www.biospace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.